GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Additional Paid-In Capital

Amicogen (XKRX:092040) Additional Paid-In Capital : ₩137,345 Mil(As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Amicogen Additional Paid-In Capital?


Amicogen's quarterly additional paid-in capital increased from Jun. 2023 (₩85,700 Mil) to Sep. 2023 (₩85,700 Mil) and increased from Sep. 2023 (₩85,700 Mil) to Dec. 2023 (₩137,345 Mil).

Amicogen's annual additional paid-in capital increased from Dec. 2021 (₩85,609 Mil) to Dec. 2022 (₩85,700 Mil) and increased from Dec. 2022 (₩85,700 Mil) to Dec. 2023 (₩137,345 Mil).

Amicogen Additional Paid-In Capital Historical Data

The historical data trend for Amicogen's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amicogen Additional Paid-In Capital Chart

Amicogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 63,253.98 63,463.55 85,609.45 85,699.86 137,344.92

Amicogen Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 85,699.86 85,699.86 85,699.86 85,699.86 137,344.92

Amicogen Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Amicogen Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Amicogen's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Amicogen (XKRX:092040) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amicogen Inc (XKRX:092040) » Definitions » Additional Paid-In Capital
Comparable Companies
XKRX:000020 XKRX:005500 XKRX:102460 XKRX:084110 XKRX:058820 XKRX:007570 XKRX:001630 XKRX:096760 XKRX:293480 XKRX:102940 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
1259-64, Dongbu-ro, Gyeongsangnam-do, Jinseong-myeon, KOR, 660-852
Website
http://www.amicogen.com
Amicogen, Inc. is an industrial biotechnology company operating in Korea. It is engaged in development, production and distribution of enzymes, bio new materials and healthcare food. The company's products portfolio includes special enzymes, N-acetylglucosamine (NAG), pinitol, D-Chiro-inositol (DCI), collagen peptides (CP) and protein A chromatography resins.

Amicogen (XKRX:092040) Headlines

No Headlines